Hospital Rawson

Córdoba 5000

0 studies enrolling now · 13 studies all time

What they study most

Covid-19, Covid19, HIV Infection, HIV Infections, HSV Infection, Influenza, Influenza A, Influenza and Other Novel Respiratory Viruses, Metapneumovirus, Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Respiratory Syncytial Virus Infections

Studies at this site

• Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects — Completed
• Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection — Completed
• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection — Stopped early
• A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus — Completed
• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications — Stopped early
• Respiratory Virus Hospitalization Study (FLU 003 Plus) — Completed
• Strategic Timing of Antiretroviral Treatment — Completed
• Immune Modulators for Treating COVID-19 — Completed
• CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients — Stopped early
• Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications — Completed
• Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus — Withdrawn before enrolling
• Respiratory Virus Outpatient Study (FLU 002 Plus) — Completed
• A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study) — Completed